ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Medicare: Clinton Budget Revives Proposal To End Physician Drug Markup

February 6, 1998

Diet Intervention Results Could Be Found In Months

April 4, 1986

NCI-Approved CTEP Trials For the Month of October

October 26, 2012

Task Force: No Routine Mammograms Until 50

November 20, 2009

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977